Bajaj Healthcare Ltd · NSE:BAJAJHCARE
Bajaj Healthcare — Investor Presentation (April 2020)
15 slides from Bajaj Healthcare's investor presentation, April 2020
Slide 1: Warm Welcome to Bajaj Healthcare Limited
Warm Welcome to BAJA] HEALTHCARE LIMITED AJAJS HEALTHCARE LTD.
Slide 2: The Company Presentation
THE COMPANY PRESENTATION «” aE COLLET EE EET TTT CECE DE BAJAJ HEALTHCARE LTD.
Slide 3: About Us
ea ABOUT US BAJAJ Bajaj Healthcare Limited is multilocational, professionally managed growing organization involved in manufacturing & distribution of various Pharmaceutical formulations of different Dosage forms & Nutraceuticals. Bajaj Healthcare Limited was established 25 years ago in 1993 & enjoy
Slide 4: Address
BAJAJ Address : 6th Floor Bhoomi Velocity Info Tech Park, Road No 23, Wagle Industrial Estate, Thane (W)- 400604, India. BAJAJ HEALTHCARE LTD. ——— A A RT A LT
Slide 5: Company Profile
Company Profile “* The unit houses a dedicated QC / QA laboratory for testing the raw materials, packing materials, in-process samples, finished products and stability products, and a separate warehouse for raw materials, finished goods and packing materials. “* Unit accredited with ISO 9001:2015 ce
Slide 6: Accreditations
Accreditations Bajaj Healthcare Ltd. — Formulation unit has following certifications like: + FDA-Gujarat * WHO-GMP * ISO-9001:2015 Food & Brugs Control Avministeation Z f., : lockionsenooe DN MET ABTAAL ite of (X eyttration Tis Coy shar (pas serena ee AT R POST [GUJARAT STATE, fas Ben dssessed anu f
Slide 7: Formulation Unit Profile
BAJA — Formulation Unit Profile Area: ¢ Total Plot Area - 3000 Sq. Mtr. ¢ Built up area - 4348 Sq. Mtr. (Four Storied Building) Capacity: ¢ Tablet : 100.0 million / month ¢ Capsule: 004.0 million / month ¢ Sachet : 001.0 million / month Departments : Production QA QC / Micro Personnel & Administrati
Slide 8: Product Portfolio
cs BAJAJ i PRODUCT PORTFOLIO Products Available : ¢ Hydroxychloroquine 200mg Tablet ¢ Hydroxychloroquine 400mg Tablet Product Capacity: * Hydroxychloroquine 200mg Tablet: 30 million per month ¢ Hydroxychloroquine 400mg Tablet: 15 million per month BAJAJ HEALTHCARE LTD.
Slide 9: Product Portfolio
PRODUCT PORTFOLIO ¢ We are pleased to inform you that the Active Pharmaceutical ingredient used in Finished Formulation of Hydroxychloroquine is also manufactured by Bajaj at its API unit Situated at Savli, Vadodara, Gujarat. * Our Savli unit was recently inspected by KFDA and we have been accredite
Slide 10: Product Rate
PRODUCT RATE | = | Product Name ote(In USD) 1 Hydroxychloroquine Sulphate USP/BP/EP USD 825 per kg 2 Hydroxychloroquine Sulfate Tablet USP USD 6 per Bottle of 30 Tablets 200mg a Hydroxychloroquine Sulfate Tablet USP USD 11.40 per Bottle of 30 400mg Tablets BAJAJ HEALTHCARE LTD.
Slide 11: Production Facility
Production Facility We have production areas for different type of products: Production Area Tablet Section : Two parallel lines with separate facilities of: ¥ Granulation ¥ Compression ¥ Coating Capsules Section Sachet Filling Section Primary and Secondary Packing Section ¥ Each section is having s
Slide 12: Production Area
Production Area BAJAJ HEALTHCARE LTD.
Slide 13: Production Area
c Production Area BAJAJ BAJAJ HEALTHCARE LTD.
Slide 14: Contact Information
re | Contact Information BAJAJ Head Office: Address: Bajaj Healthcare Ltd. 6t Floor, Bhoomi Velocity Infotech Park, Above ICICI Bank, Road No. 22, Wagle Industrial Estate, Thane (W) -400 604, Maharashtra, India. Tel: +9122 66177400 / 66177499 Fax: +9122 23410863 / 23450481 Email: bajaj@bajajhealth.c
Slide 15: Thank You
Thank You
Bajaj Healthcare — Investor Presentation (April 2020) on 6ix